Cargando…
Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment
A recent study disclosed that breast cancer cases with low ‘tau’ expression can predict susceptibility to Paclitaxel administration. In the current study, the clinical significance of tau expression in gastric cancer cases was established by identifying candidates with Paclitaxel administration. Tis...
Autores principales: | Mimori, K, Sadanaga, N, Yoshikawa, Y, Ishikawa, K, Hashimoto, M, Tanaka, F, Sasaki, A, Inoue, H, Sugimachi, K, Mori, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361361/ https://www.ncbi.nlm.nih.gov/pubmed/16721363 http://dx.doi.org/10.1038/sj.bjc.6603182 |
Ejemplares similares
-
PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression
por: Uchi, R, et al.
Publicado: (2013) -
Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer
por: Nakamura, Y, et al.
Publicado: (2007) -
Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer
por: Ishikawa, K, et al.
Publicado: (2008) -
Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases
por: Kita, Y, et al.
Publicado: (2009) -
Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood
por: Kosaka, Y, et al.
Publicado: (2007)